No drugs are currently available to treat Ebola, Dengue, or Zika viruses. Scientists have now identified key ways the three viruses hijack the body's cells, and they found at least one potential drug that can disrupt this process in human cells.
Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and monkeys from the infection.
Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.
Scientists in Brazil have discovered that more than a third of the wild monkeys they tested for Zika have been infected, the strongest evidence yet that a “reservoir” for the disease outside of humans has the potential to form.
Our conferences aim to bring together physicians, public health practitioners and researchers in various related fields in order to share knowledge, discuss new findings and new ways to further proceed, with the goal of creating valuable collaborations. The content of this conference will include: epidemiology and clinical aspects of Aedes related infections, gynecological aspects and follow up with children born to Zika infected mothers.
A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.
From mid-2015 to the end of January 2016, 47 cases of microcephaly were observed in Rio de Janeiro, Brazil. The cases were not evenly spread in proportion to the number of births; they were preferentially located in the northern suburbs apparently following the public transport routes.
In the first 15 months after they began screening blood donations for the Zika virus, the American Red Cross identified just eight true positives, at a cost of $5.3 million each.
Before a substantial response was realized, the incidence of Zika virus infections in the western hemisphere began to fall almost as fast as they had risen.
Researchers’ to-do list for tackling the Zika virus is daunting, however progress has been made.